Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Tel Aviv
  • Sector: Health Care
  • Industry: Medical Equipment & Devices
  • Sub-Industry: Health Care Supplies

InsuLine Medical Ltd

+ Add to Watchlist

INSL:IT

21.10 ILs 0.90 4.09%

As of 09:24:28 ET on 04/26/2015.

Snapshot for InsuLine Medical Ltd (INSL)

Open: 22.20 Day's Range: 21.00 - 22.20 Volume: 5,384,298
Previous Close: 22.00 52wk Range: 19.60 - 242.00 1-Yr Rtn: -90.91%

Stock Chart for INSL

No chart data available.
  • INSL:IT 21.20
  • 1D
  • 1M
  • 1Y
22.00
Interactive INSL Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for INSL

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. TA-100 -
Earnings Per Share (ttm) -0.4100
Est. EPS -
Est. PEG Ratio -
Market Cap (M ILS) 34.62
Shares Outstanding (M) 164.06
30 Day Average Volume 5,418,021
Price/Book (mrq) 1.3753
Price/Sale (ttm) 40.4222
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/27/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for INSL

  • Revenue
  • Net Income (M/ILS)
  • Profit Margin (%)

Company Profile & Key Executives for INSL

InsuLine Medical Ltd. researches medical devices for diabetes care. The Company researches devices to overcome the delay between meal glucose increase and the relatively slow absorbtion of subcutaneously injected insulin. InsuLine is researching a patch for use with infusion pumps, and a pad for use with insulin injections.

Ilan CohenChairman-Supervisory BdEyal LewinChief Executive Officer
David Ben-NaimChief Financial OfficerElmar SchaferManaging Director
More Company Profile & Key Executives for INSL

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil